News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
655,987 Results
Type
Article (65365)
Company Profile (199)
Press Release (590423)
Multimedia
Podcasts (97)
Webinars (13)
Section
Business (183011)
Career Advice (2294)
Deals (29241)
Drug Delivery (97)
Drug Development (78234)
Employer Resources (142)
FDA (14647)
Job Trends (13869)
News (310990)
Policy (28766)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (3)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (8)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (2)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2912)
Academic (2)
Accelerated approval (6)
Adcomms (22)
Allergies (76)
Alliances (49341)
ALS (88)
Alzheimer's disease (1396)
Antibody-drug conjugate (ADC) (152)
Approvals (14657)
Artificial intelligence (275)
Autoimmune disease (24)
Automation (14)
Bankruptcy (255)
Best Places to Work (10937)
BIOSECURE Act (20)
Biosimilars (81)
Biotechnology (141)
Bladder cancer (84)
Brain cancer (30)
Breast cancer (303)
Cancer (2411)
Cardiovascular disease (169)
Career advice (1923)
Career pathing (28)
CAR-T (162)
Cell therapy (454)
Cervical cancer (21)
Clinical research (62823)
Collaboration (862)
Compensation (298)
Complete response letters (18)
COVID-19 (2572)
CRISPR (43)
C-suite (229)
Cystic fibrosis (93)
Data (2149)
Decentralized trials (2)
Denatured (32)
Depression (39)
Diabetes (240)
Diagnostics (6194)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (39)
Drug discovery (130)
Drug pricing (101)
Drug shortages (22)
Duchenne muscular dystrophy (81)
Earnings (72235)
Editorial (38)
Employer branding (19)
Employer resources (125)
Events (98003)
Executive appointments (673)
FDA (15819)
Featured Employer (38)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (7)
Funding (724)
Gene editing (94)
Generative AI (27)
Gene therapy (299)
GLP-1 (670)
Government (4062)
Grass and pollen (5)
Guidances (57)
Healthcare (18104)
Huntington's disease (16)
IgA nephropathy (25)
Immunology and inflammation (111)
Indications (30)
Infectious disease (2716)
Inflammatory bowel disease (128)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (91)
Interviews (419)
IPO (13751)
IRA (47)
Job creations (3345)
Job search strategy (1637)
Kidney cancer (11)
Labor market (31)
Layoffs (421)
Leadership (17)
Legal (6626)
Liver cancer (81)
Lung cancer (345)
Lymphoma (157)
Machine learning (6)
Management (46)
Manufacturing (285)
MASH (66)
Medical device (11493)
Medtech (11497)
Mergers & acquisitions (16012)
Metabolic disorders (606)
Multiple sclerosis (76)
NASH (15)
Neurodegenerative disease (89)
Neuropsychiatric disorders (25)
Neuroscience (1901)
NextGen: Class of 2025 (6164)
Non-profit (4729)
Northern California (2390)
Now hiring (24)
Obesity (307)
Opinion (234)
Ovarian cancer (78)
Pain (79)
Pancreatic cancer (86)
Parkinson's disease (137)
Partnered (21)
Patents (204)
Patient recruitment (110)
Peanut (40)
People (51286)
Pharmaceutical (45)
Pharmacy benefit managers (12)
Phase I (19736)
Phase II (27383)
Phase III (20600)
Pipeline (1161)
Policy (149)
Postmarket research (2847)
Preclinical (9109)
Press Release (70)
Prostate cancer (113)
Psychedelics (33)
Radiopharmaceuticals (262)
Rare diseases (351)
Real estate (5691)
Recruiting (56)
Regulatory (20064)
Reports (35)
Research institute (2612)
Resumes & cover letters (349)
Rett syndrome (3)
RNA editing (5)
RSV (44)
Schizophrenia (67)
Series A (123)
Series B (73)
Service/supplier (13)
Sickle cell disease (53)
Southern California (2031)
Special edition (18)
Spinal muscular atrophy (135)
Sponsored (30)
Startups (3231)
State (2)
Stomach cancer (16)
Supply chain (58)
Tariffs (35)
The Weekly (63)
United States (21021)
Vaccines (724)
Venture capitalists (31)
Weight loss (201)
Women's health (34)
Worklife (16)
Date
Today (129)
Last 7 days (808)
Last 30 days (2422)
Last 365 days (30643)
2025 (10015)
2024 (32644)
2023 (36990)
2022 (48262)
2021 (52066)
2020 (50180)
2019 (43564)
2018 (33091)
2017 (30681)
2016 (30564)
2015 (35826)
2014 (29496)
2013 (26291)
2012 (26751)
2011 (26802)
2010 (25693)
Location
Africa (880)
Alabama (56)
Alaska (7)
Arizona (183)
Arkansas (12)
Asia (39555)
Australia (7107)
California (5415)
Canada (1785)
China (509)
Colorado (244)
Connecticut (263)
Delaware (136)
Europe (91390)
Florida (832)
Georgia (192)
Idaho (45)
Illinois (485)
India (27)
Indiana (265)
Iowa (9)
Japan (161)
Kansas (92)
Kentucky (25)
Louisiana (12)
Maine (39)
Maryland (845)
Massachusetts (4101)
Michigan (200)
Minnesota (325)
Mississippi (1)
Missouri (69)
Montana (23)
Nebraska (19)
Nevada (49)
New Hampshire (70)
New Jersey (1657)
New Mexico (29)
New York (1663)
North Carolina (926)
North Dakota (7)
Northern California (2390)
Ohio (184)
Oklahoma (15)
Oregon (33)
Pennsylvania (1224)
Puerto Rico (8)
Rhode Island (27)
South America (1178)
South Carolina (19)
Southern California (2031)
Tennessee (94)
Texas (842)
Utah (169)
Virginia (133)
Washington D.C. (59)
Washington State (550)
West Virginia (3)
Wisconsin (57)
655,987 Results for "h lee moffitt cancer center and research institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nikon Instruments Announces Moffitt Cancer Center As Newest Nikon Center of Excellence
March 5, 2025
·
2 min read
Press Releases
Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial
February 26, 2025
·
4 min read
BioMidwest
Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics
Moffitt Cancer Center, a world-renowned cancer treatment and research center, and Fulgent Pharma, a subsidiary of Fulgent Genetics, Inc. and a leading nanobiotechnology company specializing in innovative cancer therapeutics, announced a strategic partnership aimed at advancing cancer treatment through clinical development and pre-clinical co-development initiatives.
May 14, 2024
·
6 min read
Press Releases
HUNTSMAN CANCER INSTITUTE BREAKS GROUND ON COMPREHENSIVE CANCER CENTER IN VINEYARD: EXPANDING ACCESS TO WORLD-CLASS CANCER CARE AND LIFESAVING RESEARCH TO MORE UTAH COMMUNITIES
April 11, 2025
·
8 min read
Pharm Country
PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
PAVmed Inc announced that Veris and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, a National Cancer Institute-Designated Comprehensive Cancer Center, launched a pilot program and enrolled the first patients on the Veris Cancer Care Platform™ pursuant to a recently-executed memorandum of understanding.
June 13, 2024
·
5 min read
Press Releases
Immuno-Oncology Results from Research Collaboration with Léon Bérard Cancer Center Presented at AACR Annual Meeting 2025
April 30, 2025
·
5 min read
Press Releases
Moffitt Cancer Center and CMIC Group Announce Strategic Partnership to Accelerate Global Cancer Clinical Trials
September 17, 2024
·
4 min read
Pharm Country
PAVmed Subsidiary, Veris Health, Signs Memorandum of Understanding with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
PAVmed Inc. announced that Veris and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, a National Cancer Institute-Designated Comprehensive Cancer Center, have executed a memorandum of understanding to implement a pilot program where cancer patients would be enrolled on the Veris Cancer Care Platform™.
April 30, 2024
·
7 min read
News
Moffitt Cancer Center Announces Strategic Collaboration with AstraZeneca to Accelerate Oncology Cell Therapies
September 13, 2024
·
2 min read
Press Releases
Parker Institute Appoints Renowned Cancer Immunologist Dr. Ira Mellman as President of Research
April 10, 2025
·
4 min read
1 of 65,599
Next
